Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Roder, C., Thomson, M.J., Auranofin: Repurposing an old drug for a golden new age. Drugs R&D. 15(1), 13 (2015). https://doi.org/10.1007/s40268-015-0083-y
2. Hill, D.T., Sutton, B.M.: (2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S)(triethylphosphine)gold, C20H34AUO9PS. Cryst. Struct. Comm. 9, 679 (1980)
3. Chaffman, M., Brogden, R.N., Heel, R.C., Speight, T.M., Avery, G.S.: Auranofin Drugs. 27(5), 378 (1984). https://doi.org/10.2165/00003495-198427050-00002
4. Human Metabolome Database: https://hmdb.ca/metabolites/HMDB0015130
5. Boullosa, L.F., Van Loenhout, J., Hermans, C., Lau, H.W., Merlin, C., Marcq, E., Takhsha, F.S., Martinet, W., De Meyer, G.R.Y., Lardon, F., Smits, E.L.J., Deben, C.: Optimization of the solvent and in vivo administration route of Auranofin in a syngeneic Non-small Cell Lung Cancer and Glioblastoma mouse model. Pharmaceutics. 14(12), 2761 (2022). https://doi.org/10.3390/pharmaceutics14122761